Adult-specific Reelin expression alters striatal neuronal organization: implications for neuropsychiatric disorders

Front Cell Neurosci. 2023 Apr 20:17:1143319. doi: 10.3389/fncel.2023.1143319. eCollection 2023.

Abstract

In addition to neuronal migration, brain development, and adult plasticity, the extracellular matrix protein Reelin has been extensively implicated in human psychiatric disorders such as schizophrenia, bipolar disorder, and autism spectrum disorder. Moreover, heterozygous reeler mice exhibit features reminiscent of these disorders, while overexpression of Reelin protects against its manifestation. However, how Reelin influences the structure and circuits of the striatal complex, a key region for the above-mentioned disorders, is far from being understood, especially when altered Reelin expression levels are found at adult stages. In the present study, we took advantage of complementary conditional gain- and loss-of-function mouse models to investigate how Reelin levels may modify adult brain striatal structure and neuronal composition. Using immunohistochemical techniques, we determined that Reelin does not seem to influence the striatal patch and matrix organization (studied by μ-opioid receptor immunohistochemistry) nor the density of medium spiny neurons (MSNs, studied with DARPP-32). We show that overexpression of Reelin leads to increased numbers of striatal parvalbumin- and cholinergic-interneurons, and to a slight increase in tyrosine hydroxylase-positive projections. We conclude that increased Reelin levels might modulate the numbers of striatal interneurons and the density of the nigrostriatal dopaminergic projections, suggesting that these changes may be involved in the protection of Reelin against neuropsychiatric disorders.

Keywords: Reelin; Tourette’s syndrome; dopamine projections; interneurons; schizophrenia; striatum.

Grants and funding

This work was supported by grants from the Spanish MINECO and MICIN (SAF2016-76340R and PID2019-106764RB-C21, Excellence Unit 629, María de Maeztu/Institute of Neurosciences) to ES and LP, and by CIBERNED (Project: 2019-09; ISCIII, Spanish Ministry of Health) to ES, Aligning Science Across Parkinson’s through the Michael J. Fox Foundation for Parkinson’s Research, United States (ASAP-020505 to MV), Ministry of Science and Innovation (MICINN), Spain (PID2020-116339RB-I00 to MV), and EU Joint Programme Neurodegenerative Disease Research (JPND), Instituto de Salud Carlos III, EU/Spain (AC20/00121 to MV).